Literature DB >> 12885945

TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG.

Kurt A Heldwein1, Michael D Liang, Tonje K Andresen, Karen E Thomas, Aileen M Marty, Natalia Cuesta, Stefanie N Vogel, Matthew J Fenton.   

Abstract

Toll-like receptor (TLR) proteins mediate cellular activation by microbes and microbial products. To delineate the role of TLR proteins in the development of host immune responses against mycobacteria, wild-type and TLR-deficient mice were infected with nonpathogenic Mycobacterium bovis bacillus Calmette-Guerin (BCG). Two weeks after intraperitoneal challenge with BCG, few bacilli were present in the lungs of wild-type and TLR4(-/-) mice, whereas bacterial loads were tenfold higher in the lungs of infected TLR2(-/-) mice. BCG challenge in vitro strongly induced proinflammatory cytokine secretion by macrophages from wild-type and TLR4(-/-) mice but not by TLR2(-/-) macrophages. In contrast, intracellular uptake, intracellular bacterial growth, and suppression of intracellular bacterial growth in vitro by interferon-gamma (IFN-gamma) were similar in macrophages from all three mouse strains, suggesting that BCG growth in the lungs of TLR2(-/-) mice was a consequence of defective adaptive immunity. Antigenic stimulation of splenocytes from infected wild-type and TLR4(-/-) mice induced T cell proliferation in vitro, whereas T cells from TLR2(-/-) mice failed to proliferate. Unexpectedly, activated CD4(+) T cells from both TLR-deficient mouse strains secreted little IFN-gamma in vitro compared with control T cells. A role for TLR4 in the control of bacterial growth and IFN-gamma production in vivo was observed only when mice were infected with higher numbers of BCG. Thus, TLR2 and TLR4 appear to regulate distinct aspects of the host immune response against BCG.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885945     DOI: 10.1189/jlb.0103026

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  70 in total

Review 1.  New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.

Authors:  Majid Faridgohar; Hassan Nikoueinejad
Journal:  Pathog Glob Health       Date:  2017-07-17       Impact factor: 2.894

2.  Influence of the tissue microenvironment on Toll-like receptor expression by CD11c+ antigen-presenting cells isolated from mucosal tissues.

Authors:  Shunsuke Takenaka; Sarah McCormick; Ekaterina Safroneeva; Zhou Xing; Jack Gauldie
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

Review 3.  Trial Watch: Toll-like receptor agonists in cancer immunotherapy.

Authors:  Melody Smith; Elena García-Martínez; Michael R Pitter; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-10-11       Impact factor: 8.110

4.  The R753Q polymorphism in Toll-like receptor 2 (TLR2) attenuates innate immune responses to mycobacteria and impairs MyD88 adapter recruitment to TLR2.

Authors:  Goutham Pattabiraman; Rahul Panchal; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2017-04-25       Impact factor: 5.157

5.  In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs.

Authors:  Irina V Lyadova; Evgeny N Tsiganov; Marina A Kapina; Galena S Shepelkova; Vasily V Sosunov; Tatiana V Radaeva; Konstantin B Majorov; Natalya S Shmitova; Henk-Jan van den Ham; Vitaly V Ganusov; Rob J De Boer; Rachael Racine; Gary M Winslow
Journal:  PLoS One       Date:  2010-05-04       Impact factor: 3.240

6.  Induction of ER stress in macrophages of tuberculosis granulomas.

Authors:  Tracie A Seimon; Mi-Jeong Kim; Antje Blumenthal; Jovanka Koo; Sabine Ehrt; Helen Wainwright; Linda-Gail Bekker; Gilla Kaplan; Carl Nathan; Ira Tabas; David G Russell
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

7.  Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis.

Authors:  Rajesh Ravindran; Sudipta Bhowmick; Amrita Das; Nahid Ali
Journal:  BMC Microbiol       Date:  2010-06-24       Impact factor: 3.605

8.  CD36 deficiency attenuates experimental mycobacterial infection.

Authors:  Michael Hawkes; Xiaoming Li; Maryanne Crockett; Angelina Diassiti; Constance Finney; Gundula Min-Oo; W Conrad Liles; Jun Liu; Kevin C Kain
Journal:  BMC Infect Dis       Date:  2010-10-15       Impact factor: 3.090

9.  The contribution of Toll-like receptor 2 to the innate recognition of a Leishmania infantum silent information regulator 2 protein.

Authors:  Ricardo Silvestre; Ana M Silva; Anabela Cordeiro-da-Silva; Ali Ouaissi
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

10.  Novel mutations in TLR genes cause hyporesponsiveness to Mycobacterium avium subsp. paratuberculosis infection.

Authors:  Mangesh R Bhide; Rastislav Mucha; Ivan Mikula; Lucia Kisova; Rostislav Skrabana; Michal Novak; Ivan Mikula
Journal:  BMC Genet       Date:  2009-05-26       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.